(Erstwhile UTI Pharma & Healthcare Fund) Table of Contents The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on Historical performance (Yearly) on absolute basis UTI Healthcare Fund - G
Scheme Objective
CAGR
return of 14.5% since its launch. Ranked 40 in Sectoral
category. Return for 2023 was 38.2% , 2022 was -12.3% and 2021 was 19.1% . NAV as on 19 Apr 24 ₹219.451 ↓ -0.21 (-0.10 %) Net Assets (AUM) as on 31 Mar 2024 ₹947 Cr. Launch Date 28 Jun 1999 Category Equity - Sectoral Rating ☆ Type Open Ended Fund Risk High AMC UTI Asset Management Company Ltd Alpha Ratio -1.02 Expense Ratio 2.47 % Sharpe Ratio 2.738 Information Ratio -0.55 Benchmark Not Available Min Investment ₹5,000 Min SIP Investment ₹500 Exit Load 0-1 Years (1%),1 Years and above(NIL) NAV Price Chart
Returns
Annual Compounded Returns
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 19 Apr 24 Duration Returns 1 Month 2% 3 Month 3.8% 6 Month 19% 1 Year 46.4% 3 Year 13.9% 5 Year 20.5% 10 Year 15 Year Since launch 14.5% Historical Annual Returns
Year Returns 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Growth of 10k Over Years
Date Value 31 Mar 19 ₹10,000 31 Mar 20 ₹9,301 31 Mar 21 ₹16,181 31 Mar 22 ₹18,227 31 Mar 23 ₹16,648 31 Mar 24 ₹25,935 Asset Allocation
Asset Class Value Cash 1.54% Equity 98.33% Debt 0.13% Sector Allocation
Sector Value Health Care 96.45% Basic Materials 1.29% Financial Services 0.59% Top Securities Holdings / Portfolio
Holdings/Securities
Name Global Industry Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMADrug Manufacturers - Specialty & Generic 14% ₹133 Cr 840,000 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087Drug Manufacturers - General 8% ₹74 Cr 500,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSPMedical Care Facilities 7% ₹63 Cr 103,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDYDrug Manufacturers - Specialty & Generic 6% ₹60 Cr 92,920
↓ -5,723 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 532331Drug Manufacturers - Specialty & Generic 6% ₹55 Cr 247,524
↑ 37,372 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMADrug Manufacturers - Specialty & Generic 4% ₹38 Cr 371,376
↓ -8,624 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Jun 21 | 543308Medical Care Facilities 4% ₹34 Cr 152,643
↓ -8,691 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 532843Medical Care Facilities 4% ₹34 Cr 839,326
↓ -10,944 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 14 | TORNTPHARMDrug Manufacturers - Specialty & Generic 3% ₹32 Cr 120,080 Suven Pharmaceuticals Ltd (Healthcare)
Equity, Since 28 Feb 21 | SUVENPHARDrug Manufacturers - Specialty & Generic 3% ₹28 Cr 440,000
Talk to our investment specialistFund Managers
Name Since Tenure Kamal Gada 2 May 22 1.92 Yr. Custodians
Company Address Bank of Nova Scotia 12/13, Maker Chamber VI,220, Nariman Point Citibank N.A. India Trent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East), Stock Holding Corporation of India Mittal Court, ‘B’ Wing,,Nariman Point Registrar & Transfer Agent
KFin Technologies Ltd Address KFin Technologies Pvt. Ltd,,1D/D Extension 2, Valmiki Chowk,,Gandhi Nagar, FAX 91-40-23311968 Email mailmanager@karvy.com Administrator Companies
Company Address UTI Mutual Fund UTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E) Auditors
Company Address Haribhakti & Co. Chartered Accountants 42, Free Press House,4th Floor,,215, Nariman Point, All Plan & Options
Fund and Plan NAV 6 Month 1 Year 3 Year 5 Year UTI Healthcare Fund
Growth ₹219.451
↓ -0.21 18.96 % 46.39 % 13.88 % 20.54 % UTI Healthcare Fund
Normal Dividend, Payout ₹169.605
↓ -0.17 18.96 % 46.39 % 13.88 % 20.54 % UTI Healthcare Fund
Normal Dividend, Reinvestment ₹169.605
↓ -0.17 18.96 % 46.39 % 13.88 % 20.54 % Data as on 19 Apr 24